Treatment of atrial fibrillation.
D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000503:physiopathology / Q000601:surgery; D017115:Catheter Ablation; D004502:Education, Medical, Continuing; D006801:Humans; D017410:Practice Guidelines as Topic; D013917:Thrombin / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D013917:Thrombin